Stockholm Stock Exchange | Large Cap
Vitrolife
+90.71%
Latest
-
3 months
DNB CarnegieSEBCarnegieSEB EquitiesHandelsbankenDNBHandelsbanken Capital MarketsDNB Markets

Price Targets For Vitrolife

AnalystPrice TargetDateUpside
DNB Carnegie230 SEKOct -25
+90.71%
SEB170 SEKSep -25
Carnegie265 SEKMar -25
SEB Equities275 SEKOct -24
Handelsbanken250 SEKJul -24
DNB250 SEKJul -24
Handelsbanken Capital Markets220 SEKJan -24
DNB Markets220 SEKJan -24

About The Company

Vitrolife is a Swedish medtech company which sells products for IVF treatment.
Wikipedia